Tazzyman, S.; Stewart, G.R.; Yeomans, J.; Linford, A.; Lath, D.; Conner, J.; Muthana, M.; Chantry, A.D.; Lawson, M.A.
HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models. Viruses 2023, 15, 603.
https://doi.org/10.3390/v15030603
AMA Style
Tazzyman S, Stewart GR, Yeomans J, Linford A, Lath D, Conner J, Muthana M, Chantry AD, Lawson MA.
HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models. Viruses. 2023; 15(3):603.
https://doi.org/10.3390/v15030603
Chicago/Turabian Style
Tazzyman, Simon, Georgia R. Stewart, James Yeomans, Adam Linford, Darren Lath, Joe Conner, Munitta Muthana, Andrew D. Chantry, and Michelle A. Lawson.
2023. "HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models" Viruses 15, no. 3: 603.
https://doi.org/10.3390/v15030603
APA Style
Tazzyman, S., Stewart, G. R., Yeomans, J., Linford, A., Lath, D., Conner, J., Muthana, M., Chantry, A. D., & Lawson, M. A.
(2023). HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models. Viruses, 15(3), 603.
https://doi.org/10.3390/v15030603